Molecular master switch for pancreatic cancer identified, potential predictor of treatment outcome

A recently described master regulator protein may explain the development of aberrant cell growth in the pancreas spurred by inflammation. The Penn team profiled gene expression of mouse pancreatic ductal and duct-like cells from different states — embryonic development, acute pancreatitis and K-ras mutation-driven carcinogenesis — to find the molecular regulation of these processes.

Fuente : http://www.eurekalert.org/pub_releases/2013-02/uop…



Hacer un comentario